Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial

BACKGROUND: Optimal antimicrobial drug exposure in the lung is required for successful treatment outcomes for nosocomial pneumonia. Little is known about the intrapulmonary pharmacokinetics (PK) of meropenem when administered by continuous infusion (CI). The aim of this study was to evaluate the PK...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Crit Care
Main Authors: Benítez-Cano, Adela, Luque, Sonia, Sorlí, Luisa, Carazo, Jesús, Ramos, Isabel, Campillo, Nuria, Curull, Víctor, Sánchez-Font, Albert, Vilaplana, Carles, Horcajada, Juan P., Adalia, Ramón, Bermejo, Silvia, Samsó, Enric, Hope, William, Grau, Santiago
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7026992/
https://ncbi.nlm.nih.gov/pubmed/32066497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-020-2763-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados